Skip to main content

Cordova Ashley's Form 4 filing

NovoCure Ltd (NVCR) · filed Mar 7, 2022

Accession no.
0001645113-22-000022
Filed
Mar 7, 2022
Trade date
Mar 3-4, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $124.7K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Cordova AshleyCIK 0001822014Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 3, 2022Ordinary SharesAGrant or awardAcquired+21,508$0.00$063,312Direct
Mar 3, 2022Ordinary SharesSSaleDisposed−1,149$74.50−$85,600.562,163Direct
Mar 4, 2022Ordinary SharesSSaleDisposed−556$70.41−$39,147.9661,607Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 3, 2022Ordinary SharesAGrant or awardAcquired+37,664$80.59+$3,035,341.7637,664Direct
Mar 3, 2022Ordinary SharesAGrant or awardAcquired+5,140$80.59+$414,232.65,140Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)